, pub-5475981771945671, DIRECT, f08c47fec0942fa0

Singapore approves access to Sinovac vaccine through private healthcare sector - The Star Online

SINGAPORE (The Straits Times/ANN): Sinovac’s Covid-19 vaccine will be allowed under the Special Access Route (SAR), said the Ministry of Health (MOH) on Wednesday (June 2).

This follows the announcement by the World Health Organization (WHO) on Tuesday that it had approved the shot under its Emergency Use Listing.

In response to queries from The Straits Times, MOH said that given this latest development, the Sinovac product would be allowed under the SAR.

However, since the China-made vaccine is not part of the national programme, those who choose to receive it will not be eligible for the Vaccine Injury Financial Assistance Programme (Vifap).

MOH said it will release more details in the coming days on how private healthcare institutions can apply to be licensed providers.

It added that it is working out details on pricing, informed consent process and safety of the patients who prefer to be administered with Sinovac’s shot.

Health Minister Ong Ye Kung had said on Monday that licensed healthcare institutions can apply to MOH to draw on Singapore’s existing stock of 200,000 doses of the vaccine, which were delivered earlier this year.

However, MOH clarified on Wednesday that this is still a possibility that is being assessed.

“As more international and local evidence and data becomes available, the Expert Committee on Covid-19 vaccination is also reviewing current restrictions to allow people with known history of anaphylaxis to be vaccinated, with the two mRNA vaccines currently approved for use here,” said MOH, adding that this will enable more people to be protected.

The two mRNA vaccines refer to those by Moderna and Pfizer-BioNTech. Both use messenger RNA to give instructions to the body’s cells to produce a harmless piece of the spike protein found on the surface of the coronavirus that causes Covid-19. This allows the body to protect itself from the disease.

In contrast, Sinovac uses an inactivated form of the coronavirus to teach the body how to protect itself from Covid-19. – The Straits Times/Asia News Network